Turnstone Biologics Quote - TSBX

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

2.25

Bid

2.26

Offer

2.33

Volume

59,059

2.2001 Day's Range 2.4099

1.625 52 Week Range 13.20

Market Cap

52.039M

Previous Close

2.31

Open

2.40

Last Trade

100

2.31

(formt)

Last Trade Time

Financial Volume

US$ 138,055

VWAP

2.3376

Average Volume (3m)

162,744

Shares Outstanding

23,128,454

Dividend Yield

PE Ratio

-0.94

Earnings Per Share (EPS)

-2.39

Revenue

19.31M

Net Profit

-55.2M

Turnstone Biologics Corp. is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The Company is focused on developing tumor infiltrating lymphocytes (TIL) therapies designed to drive clinical benefit and curative outcomes across mu... Turnstone Biologics Corp. is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The Company is focused on developing tumor infiltrating lymphocytes (TIL) therapies designed to drive clinical benefit and curative outcomes across multiple solid tumors. Its selected TIL approach focuses on selecting and expanding potent tumor-reactive T cells to overcome the limitations of bulk TILs. Its pipeline includes TIDAL-01 and TIDAL-02. Its lead selected TIL product candidate, TIDAL-01, utilizes an unbiased identification and functional screening process to isolate and selectively expand the breadth of tumor-reactive TILs from the patient¿s tumor. Its next selected TIL program, TIDAL-02, is being designed to encompass a streamlined manufacturing process for tumor-reactive T cells and additional modifications to enhance TIL quality and function. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Headquarters

La Jolla, California, USA

Founded

1970

Turnstone Biologics Corporation is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker TSBX. The last closing price for Turnstone Biologics was US$2.31. Over the last year, Turnstone Biologics shares have traded in a share price range of US$ 1.625 to US$ 13.20.

Turnstone Biologics currently has 23,128,454 shares in issue. The market capitalisation of Turnstone Biologics is US$52.04 million. Turnstone Biologics has a price to earnings ratio (PE ratio) of -0.94.

Period †	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.58	-20.4946996466	2.83	3	2.25	422466	2.61747475	CS
4	-0.53	-19.0647482014	2.78	3.05	2.25	187649	2.6873437	CS
12	-1.01	-30.981595092	3.26	3.8782	2.25	162744	2.81290674	CS
26	-0.26	-10.3585657371	2.51	5.75	1.8	170482	2.94219307	CS
52	-9.15	-80.2631578947	11.4	13.2	1.625	130235	3.69109005	CS
156	-9.15	-80.2631578947	11.4	13.2	1.625	130235	3.69109005	CS
260	-9.15	-80.2631578947	11.4	13.2	1.625	130235	3.69109005	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
PNTOAPanther Metals Ltd	AUD 0.002 (100.00%)	550k
EQSEquity Story Group Ltd	AUD 0.022 (46.67%)	268.32k
PUAPeak Minerals Limited	AUD 0.005 (42.86%)	33.82M
EXLElixinol Wellness Limited	AUD 0.004 (33.33%)	4.91k
M2MOMT Malcolm Mines NL	AUD 0.008 (33.33%)	3.08M
TMGODTrigg Minerals Ltd	AUD 0.001 (-50.00%)	16.03M
MTLMantle Minerals Limited	AUD 0.002 (-33.33%)	203.44k
LITOALithium Australia Ltd	AUD 0.002 (-33.33%)	100.65k
MRQMRG Metals Ltd	AUD 0.004 (-27.27%)	78.39M
TMGTrigg Minerals Ltd	AUD 0.009 (-21.74%)	1.15M
MRQOMRG Metals Limited	AUD 0.001 (0.00%)	97.25M
MRQMRG Metals Ltd	AUD 0.004 (-27.27%)	78.39M
M2MMt Malcolm Mines NL	AUD 0.041 (20.59%)	38.05M
PUAPeak Minerals Limited	AUD 0.005 (42.86%)	33.82M
AL3AML3D Limited	AUD 0.21 (23.53%)	29.41M